Search results - 2 results
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
estimate incidence, describe clinical presentation and investigate factors associated with severe outcomes using multivariable analysis. RESULTS: Up to December 31, 2020, 26 countries reported information on ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
1555 people with CF, 1452 were included in the analysis. One third were aged <18 years, and 9.4% were solid-organ transplant recipients. 74.5% were symptomatic and 22% were admitted to hospital. In ...